Japan aims to accelerate its vaccine research and development under a new government body after lagging behind other advanced countries in developing vaccines during the early stages of the coronavirus pandemic.

The Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) was established in late March within the Japan Agency for Medical Research and Development to promptly deliver safe and effective vaccines against infectious diseases on the government’s priority list.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.